Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nasar Ata

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|June 12, 2026
Longitudinal and Stability-Aware Analysis Reveals Treatment-Specific MicroRNA Response Signatures Following Immune-Reconstitution and B-Cell-Targeted Therapies in Multiple SclerosisNasar Ata, Joshua S Mytych, Mirela Cerghet, et al.
Metabolites|September 27, 2024
Utility of an Untargeted Metabolomics Approach Using a 2D GC-GC-MS Platform to Distinguish Relapsing and Progressive Multiple SclerosisIndrani Datta, Insha Zahoor, Nasar Ata, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Utility of an untargeted metabolomics approach using a 2D GC-GC-MS platform to distinguish relapsing and progressive multiple sclerosisIndrani Datta, Insha Zahoor, Nasar Ata, et al.
Multiple Sclerosis and Related Disorders|October 29, 2024
Artificial neural network-based prediction of multiple sclerosis using blood-based metabolomics dataNasar Ata, Insha Zahoor, Nasrul Hoda, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Blood-based targeted metabolipidomics reveals altered omega fatty acid-derived lipid mediators in relapsing-remitting multiple sclerosis patientsInsha Zahoor, Jeffrey Waters, Nasar Ata, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|June 12, 2026
Longitudinal and Stability-Aware Analysis Reveals Treatment-Specific MicroRNA Response Signatures Following Immune-Reconstitution and B-Cell-Targeted Therapies in Multiple SclerosisNasar Ata, Joshua S Mytych, Mirela Cerghet, et al.
Metabolites|September 27, 2024
Utility of an Untargeted Metabolomics Approach Using a 2D GC-GC-MS Platform to Distinguish Relapsing and Progressive Multiple SclerosisIndrani Datta, Insha Zahoor, Nasar Ata, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Utility of an untargeted metabolomics approach using a 2D GC-GC-MS platform to distinguish relapsing and progressive multiple sclerosisIndrani Datta, Insha Zahoor, Nasar Ata, et al.
Multiple Sclerosis and Related Disorders|October 29, 2024
Artificial neural network-based prediction of multiple sclerosis using blood-based metabolomics dataNasar Ata, Insha Zahoor, Nasrul Hoda, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Blood-based targeted metabolipidomics reveals altered omega fatty acid-derived lipid mediators in relapsing-remitting multiple sclerosis patientsInsha Zahoor, Jeffrey Waters, Nasar Ata, et al.
Pageof 1